Relocated to develop corporate aspirations and long term strategic and financial projections for Alexion Pharmaceuticals.• Contribute to construction of annual corporate strategic plan.• Charged with drawing out near and long-term functional implications, translating enterprise strategy into meaningful goals and initiatives at the functional level.

Led the creation, communication and execution of the Zoetis 5-year Global Strategic Plan, targeting investments to achieve $200M growth per annum.• Facilitated and supported execution of regional and local business strategic plans aligned with global plan to drive growth.• Key contributor to development of Zoetis global manufacturing strategy, leading to 1.3% improvement in production margin over 5 years.• Developed SEC and Investor Relations materials to ensure a cohesive story aligned with the company’s global strategic plan.• Primary contact for management consultancy vendors including McKinsey, BCG, IBM, and Bain.

Promoted to guide 16 team members charged with leading projects through asset and portfolio decision making processes.• Initiated, led and executed a structured project and portfolio valuation and prioritization process using P&L and Probability of Success-based metrics for all development R&D projects in a $2B portfolio. Created the financial model and macros that enable real-time risk-adjusted valuation of any asset and of the entire portfolio, resulting in a $100M increase in risk-adjusted portfolio value in the first year.• Designed and created online training modules for leaders and participants in asset valuations at project stage-gates, with more than 300 colleagues completing the training to date.• Led teams providing commercial input to progression plan decisions for projects including >$100M product Apoquel™.• Managed the Portfolio Review Committee, the main pipeline decision-making body, made up of key leaders across the organization.• Reviewed and streamlined processes for developing new product strategy for each of the 18 major Therapeutic Areas. Initiated and led creation of teams and processes to execute and track strategy for each therapeutic area, and to summarize progress for leadership.• Drove creation of simplified, cost effective software platform for global sharing of marketing materials and plans, with 6000 items currently included.• Created a structured process for proposing and evaluating lifecycle activities for existing assets; now in its sixth year, it has received over 1000 proposals. Developed online self-service training program on the process.

Led multidisciplinary teams to identify unmet needs, evaluate opportunities and decide optimum progression plans for biological and pharmaceutical projects.• Directed cross-functional teams for commercialization and strategic life cycle planning of imminent and recently launched Companion Animal products to maximize long term revenues.• lanned and executed the successful global launch of $150M product Convenia.

Led cross-functional teams in the development and execution of the marketing strategy for Companion Animal products, achieving 14% annual growth over three years.

Coordinated and led the local Marketing/Technical/Sales team including marketing planning, and sales cycle execution. Redesigned the national discount scheme resulting in increased revenue.